Company: INV
Filing Date: 2025-11-12
Form Type: 424B3
Source: 0001140361-25-041464
Chunk: 17

Company: Innventure, Inc.
Filing Date: 2025-11-12
Form: 424B3
Chunk 17
---
 price and conversion price, each of which is 80% of the JCI Issue Price (as defined below) and, initially though subject to possible later adjustment, the JCI Conversion Price (as defined below), respectively. Concurrently with the conversion, the Company issued warrants to the lenders exercisable for Accelsius’ Series B-2 Units. These warrants are exercisable for 0.5 Series B-2 Units for every 1 Series B-2 Unit that was issued as part of the conversion. The exercise price for the warrants was set at 120% of the price the units in the Next Funding Round are sold.

<div align='center'>5</div>

#### TABLE OF CONTENTS

#### JCI Investment in Accelsius
On October 2, 2025 (the “JCI Closing” or “JCI Closing Date”), Accelsius issued and sold to Johnson Controls, Inc., a Wisconsin corporation (“JCI”), 685,163 units of Accelsius’s Series B-1 Units (the “Series B-1 Units”). The gross proceeds to the Company from the JCI Closing were approximately $25,000,000 before deducting financial advisor fees and other estimated offering expenses.

Accelsius will use the proceeds from the sale of the Series B-1 Units for general company purposes. Upon consummation of the JCI Closing, certain outstanding convertible notes and other indebtedness of Accelsius that is automatically convertible into equity securities of Accelsius automatically converted into equity securities of Accelsius in accordance with their terms (please see the “Accelsius Convertible Notes” disclosure above). The Series B-1 Units are convertible at any time and from time to time into Accelsius’s Class A Comon Units by dividing the Series B-1 Unit’s JCI Issue Price (as defined below) by the JCI Conversion Price (as defined below) in effect at the time of conversion. The “JCI Issue Price” means $36.4877 per unit, subject to appropriate adjustment in the event of any unit dividend, unit split, combination or other similar recapitalization with respect to the applicable Series B-1 Units. The “JCI Conversion Price” shall initially equal $36.4877 and will be subject to certain adjustments.

In connection with the Closing, Accelsius amended its limited liability company agreement (“Operating Agreement”) to provide for certain rights to JCI with respect to the Series B-1 Units.

Management Rights

For so long as JCI and its affiliates continue to beneficially own an